Deal Details

GTCR Makes Strategic Minority Investment in Solmetex

Healthcare

GTCR strategic minority investment in Solmetex, a portfolio company of AGIC

Summary

GTCR, LLC (“GTCR”) has made a $200 Million strategic minority investment in Solmetex, LLC (“Solmetex” or the “Company”), a portfolio company of AGIC Capital (“AGIC”).

Baird served as financial advisor to GTCR on this transaction.

About

Founded in 1980, GTCR is a leading private equity firm that invests behind The Leaders Strategy™ – finding and partnering with management leaders in core domains to identify, acquire and build market-leading companies through organic growth and strategic acquisitions. GTCR is focused on investing in transformative growth in companies in the Business & Consumer Services, Financial Services & Technology, Healthcare and Technology, Media & Telecommunications sectors. Since its inception, GTCR has invested more than $30 billion in approximately 300 companies, and the firm currently manages approximately $50 billion in equity capital. With offices in New York and West Palm Beach, GTCR is headquartered in Chicago, Illinois.

Founded in 1994, Solmetex was established as a dental water treatment consumables company focused on safely supporting the removal of mercury waste from dental offices. Today, the Company serves more than 85,000 dental practices across the U.S., providing trusted solutions for their amalgam separation needs. Through a series of strategic acquisitions, Solmetex has expanded its portfolio beyond amalgam separation to include systems and consumables for dental waterline treatment and testing, advanced dental isolation solutions and regenerative biomaterials. These additions have established Solmetex as a comprehensive, trusted platform delivering innovative solutions that are relevant to every dental practice. Solmetex is headquartered in Northborough, Massachussetts.

AGIC is a growth-oriented private equity firm that invests in thriving middle-market businesses focused on advanced industrial and healthcare technologies in Europe and beyond. AGIC’s differentiated investment strategy combines deep business model expertise and proactive thematic research with a collaborative, management-first approach to value creation. Launched in 2015, AGIC currently has $2.2 billion in assets under management. The firm’s more than 25 professionals are based in Europe and Asia. AGIC is headquartered in Munich, Germany.

Healthcare

GTCR strategic minority investment in Solmetex, a portfolio company of AGIC